TABLE 1.
Clinicopathological parameters of the studied cases.
| Value (range) | ||
|---|---|---|
| Median age (years) | 59 (29–81) | |
| Median tumor size (mm) | 20 (7–107) | |
| Histological type | ||
| NST | 98 | |
| Mixed micropapillary | 3 | |
| Metaplastic | 5 | |
| pT category | ||
| pT1 | 55 | |
| pT2 | 43 | |
| pT3 | 4 | |
| pT4 | 4 | |
| pN category | ||
| pN0 | 57 | |
| pN1 | 37 | |
| pN2 | 10 | |
| pN3 | 2 | |
| Grade | ||
| 1 | 0 | |
| 2 | 5 | |
| 3 | 101 | |
| Surgery type | ||
| Breast-conservative | 80 | |
| Mastectomy | 26 | |
| SNB | 56 | |
| SNB and ALND | 24 | |
| ALND | 25 | |
| No axillary surgery | 1 | |
| Chemo and Radiotherapy | ||
| Taxane containing therapy | 67 | |
| Anthracyclin containing therapy | 12 | |
| CMF | 4 | |
| RT | 83 | |
| Only RT without Chemotherapy | 9 | |
| Neither chemotherapy nor RT | 14 | |
NST: no special type breast cancer, SNB: sentinel lymph node biopsy, ALND: Level I-II axillary lymph node dissection, CMF: cyclophosphamide, methotrexate, and fluorouracil, RT: radiotherapy